Michael Ghadimi
Overview
Explore the profile of Michael Ghadimi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
2219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Diefenhardt M, Martin D, Fleischmann M, Hofheinz R, Ghadimi M, Rodel C, et al.
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518112
Additional adjuvant treatment in patients with rectal cancer with limited response to neoadjuvant treatment to mitigate their higher risk of treatment failure remains controversial. This is a post hoc analysis...
12.
Stoop T, Augustinus S, Bjornsson B, Tingstedt B, Andersson B, Wolfgang C, et al.
Ann Surg Oncol
. 2024 Oct;
31(13):8768-8769.
PMID: 39402315
No abstract available.
13.
von Heesen M, Ghadimi M
Chirurgie (Heidelb)
. 2024 Oct;
95(11):878-886.
PMID: 39387920
A leakage of a colorectal anastomosis represents a severe complication in visceral surgery. An anastomotic insufficiency (AI) is a potentially life-threatening complication for patients that carries a high risk of...
14.
de Graaf N, Augustinus S, Wellner U, Johansen K, Andersson B, Beane J, et al.
Surg Endosc
. 2024 Sep;
38(12):7099-7111.
PMID: 39342074
Background: Minimally invasive pancreatoduodenectomy (MIPD) has emerged as an alternative to open pancreatoduodenectomy (OPD). However, the extent of variation in the use and outcomes of MIPD in relation to OPD...
15.
Hofheinz R, Arnold D, Borner M, Eisterer W, Folprecht G, Ghadimi M, et al.
Oncol Res Treat
. 2024 Sep;
47(12):610-615.
PMID: 39288743
This article briefly summarizes clinically relevant new aspects of the recently published German, Austrian, and Swiss Onkopedia guideline for the treatment of locally advanced rectal cancer. Main aspects comprise (i)...
16.
Diefenhardt M, Martin D, Hofheinz R, Ghadimi M, Fokas E, Rodel C, et al.
JAMA Netw Open
. 2024 Sep;
7(9):e2432927.
PMID: 39264626
Importance: Patients with locally advanced rectal cancer and persistent lymph node metastases (PLNM) after neoadjuvant treatment are at high risk of developing locoregional and distant metastasis, yet optimal postsurgical treatment...
17.
Tapia Contreras C, Falke J, Seifert D, Schneider C, Krauss L, Fang X, et al.
Mol Oncol
. 2024 Sep;
19(2):295-310.
PMID: 39253995
Pancreatic ductal adenocarcinoma (PDAC) has limited treatment options, emphasizing the urgent need for effective therapies. The predominant driver in PDAC is mutated KRAS proto-oncogene, KRA, present in 90% of patients....
18.
Fokas E, Williams H, Diefenhardt M, Lin S, Qin L, Piso P, et al.
Eur J Cancer
. 2024 Aug;
210:114291.
PMID: 39180940
Background: Total neoadjuvant therapy (TNT) has been used for patients with locally advanced rectal cancer. The optimal sequence of chemoradiotherapy (CRT) and chemotherapy (CT) is a matter of debate. Methods:...
19.
Moreno P, Ohara Y, Craig A, Liu H, Yang S, Dorsey T, et al.
Carcinogenesis
. 2024 Aug;
45(11):845-856.
PMID: 39136088
Pancreatic ductal adenocarcinoma (PDAC) manifests diverse molecular subtypes, including the classical/progenitor and basal-like/squamous subtypes, with the latter known for its aggressiveness. We employed integrative transcriptome and metabolome analyses to identify...
20.
Stoop T, Augustinus S, Bjornsson B, Tingstedt B, Andersson B, Wolfgang C, et al.
Ann Surg Oncol
. 2024 Aug;
31(12):8327-8339.
PMID: 39120839
Background: Pancreatic adenocarcinoma located in the pancreatic body might require a portomesenteric venous resection (PVR), but data regarding surgical risks after distal pancreatectomy (DP) with PVR are sparse. Insight into...